Free Trial
NASDAQ:SION

Sionna Therapeutics (SION) Stock Price, News & Analysis

Sionna Therapeutics logo
$26.69 +0.80 (+3.09%)
As of 02:56 PM Eastern

About Sionna Therapeutics Stock (NASDAQ:SION)

Advanced

Key Stats

Today's Range
$25.34
$26.99
50-Day Range
$16.74
$25.89
52-Week Range
$7.26
$26.99
Volume
142,409 shs
Average Volume
201,927 shs
Market Capitalization
$1.18 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$38.00
Consensus Rating
Buy

Company Overview

Sionna Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
51st Percentile Overall Score

SION MarketRank™: 

Sionna Therapeutics scored higher than 51% of companies evaluated by MarketBeat, and ranked 500th out of 946 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sionna Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

  • Upside Potential

    Sionna Therapeutics has a consensus price target of $38.00, representing about 48.7% upside from its current price of $25.55.

  • Amount of Analyst Coverage

    Sionna Therapeutics has only been the subject of 3 research reports in the past 90 days.

  • Read more about Sionna Therapeutics' stock forecast and price target.
    • Percentage of Shares Shorted

      14.88% of the float of Sionna Therapeutics has been sold short.
    • Short Interest Ratio / Days to Cover

      Sionna Therapeutics has a short interest ratio ("days to cover") of 16, which indicates bearish sentiment.
    • Change versus previous month

    • Dividend Yield

      Sionna Therapeutics does not currently pay a dividend.

    • Dividend Growth

      Sionna Therapeutics does not have a long track record of dividend growth.

    • Percentage of Shares Shorted

      14.88% of the float of Sionna Therapeutics has been sold short.
    • Short Interest Ratio / Days to Cover

      Sionna Therapeutics has a short interest ratio ("days to cover") of 16, which indicates bearish sentiment.
    • Change versus previous month

    • News Sentiment

      Sionna Therapeutics has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Medical companies.
    • News Coverage This Week

      MarketBeat has tracked 3 news articles for Sionna Therapeutics this week, compared to 3 articles on an average week.
    • Insider Buying vs. Insider Selling

      In the past three months, Sionna Therapeutics insiders have sold 54.32% more of their company's stock than they have bought. Specifically, they have bought $950,400.00 in company stock and sold $1,466,671.00 in company stock.

    • Percentage Held by Insiders

      Only 3.90% of the stock of Sionna Therapeutics is held by insiders.

    • Read more about Sionna Therapeutics' insider trading history.
    Receive SION Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Sionna Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

    By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    SION Stock News Headlines

    Out of 18,347 Cryptocurrencies... This is the ONLY One
    The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should buy in this market, this token might just be it.tc pixel
    See More Headlines

    SION Stock Analysis - Frequently Asked Questions

    Sionna Therapeutics' stock was trading at $20.10 on January 1st, 2025. Since then, SION shares have increased by 27.1% and is now trading at $25.55.

    Sionna Therapeutics, Inc. (NASDAQ:SION) announced its earnings results on Monday, August, 11th. The company reported ($0.41) EPS for the quarter, topping analysts' consensus estimates of ($0.68) by $0.27.

    Sionna Therapeutics (SION) raised $191 million in an IPO on Friday, February 7th 2025. The company issued 10,588,233 shares at $18.00 per share.

    Sionna Therapeutics's lock-up period expired on Wednesday, August 6th. Sionna Therapeutics had issued 10,588,233 shares in its initial public offering on February 7th. The total size of the offering was $190,588,194 based on an initial share price of $18.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the end of the lock-up period.

    Top institutional investors of Sionna Therapeutics include Viking Global Investors LP (7.24%), JPMorgan Chase & Co. (5.03%), Perceptive Advisors LLC (2.75%) and Braidwell LP (2.45%). Insiders that own company stock include Tpg Gp A, Llc and Michael Cloonan.
    View institutional ownership trends
    .

    Shares of SION stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Company Calendar

    Last Earnings
    8/11/2025
    Today
    9/23/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED - BIOMED/GENE
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:SION
    Previous Symbol
    NASDAQ:SION
    CIK
    2036042
    Web
    N/A
    Fax
    N/A
    Employees
    35
    Year Founded
    N/A

    Price Target and Rating

    High Price Target
    $46.00
    Low Price Target
    $22.00
    Potential Upside/Downside
    +46.8%
    Consensus Rating
    Buy
    Rating Score (0-4)
    3.00
    Research Coverage
    6 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    N/A
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    N/A
    Net Margins
    N/A
    Pretax Margin
    N/A
    Return on Equity
    N/A
    Return on Assets
    N/A

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    35.33
    Quick Ratio
    35.33

    Sales & Book Value

    Annual Sales
    N/A
    Price / Sales
    N/A
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    N/A
    Price / Book
    N/A

    Miscellaneous

    Outstanding Shares
    44,140,000
    Free Float
    42,419,000
    Market Cap
    $1.14 billion
    Optionable
    N/A
    Beta
    N/A
    Metaverse Stocks And Why You Can't Ignore Them Cover

    Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

    Get This Free Report

    This page (NASDAQ:SION) was last updated on 9/23/2025 by MarketBeat.com Staff
    From Our Partners